Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 07, 2021

SELL
$574.03 - $680.96 $4.71 Million - $5.59 Million
-8,213 Closed
0 $0
Q2 2021

Jul 20, 2021

SELL
$472.8 - $558.54 $5.2 Million - $6.14 Million
-10,994 Reduced 57.24%
8,213 $4.59 Million
Q1 2021

Apr 28, 2021

BUY
$446.73 - $548.2 $2.54 Million - $3.12 Million
5,687 Added 42.06%
19,207 $9.09 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $6.47 Million - $8.22 Million
13,520 New
13,520 $6.53 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $99.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vancity Investment Management LTD Portfolio

Follow Vancity Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vancity Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Vancity Investment Management LTD with notifications on news.